Cariprazine Hydrochloride

CAS 1083076-69-0 16 current recordsSmall Molecule

Who holds supplier records for Cariprazine Hydrochloride? 16 organisations hold a current record for Cariprazine Hydrochloride: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (10), China (3), Hungary (1) and Argentina (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Cariprazine Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/cariprazine-hydrochloride

Reading the evidence

  • 16 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    10 of the 15 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 10 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (16)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Cariprazine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

India10China3Hungary1Argentina1Country not recorded for 1
Need Cariprazine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Cariprazine Hydrochloride is an atypical antipsychotic used in the treatment of schizophrenia and bipolar disorder. It acts as a partial agonist at D2 and D3 dopamine receptors, providing therapeutic effects on both positive and negative symptoms.

Chemical identity

IUPAC name
3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethylurea;hydrochloride
Canonical SMILES
CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl.Cl
InChIKey
GPPJWWMREQHLQT-UHFFFAOYSA-N
Synonyms
Vraylar API, cariprazine hcl, rgh-188 hcl, vraylar

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Atypical Antipsychotic

Therapeutic areas

PsychiatryBipolar DisorderSchizophrenia

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Cariprazine Hydrochloride?

16 organisations hold an active US FDA Type II Drug Master File or a CEP for Cariprazine Hydrochloride: BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) (India), APITORIA PHARMA PRIVATE LTD (India), CHEMECA DRUGS PRIVATE LTD (India), Gedeon Richter (Hungary), HIKAL LTD (India), HONOUR LAB LTD (India) and HQ PHARMA (SHANGHAI) CO LTD, and 8 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Cariprazine Hydrochloride Drug Master Files are active?

BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 41753, 33846), AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) (DMF 41657), APITORIA PHARMA PRIVATE LTD (DMF 33956), CHEMECA DRUGS PRIVATE LTD (DMF 44509), Gedeon Richter (DMF 26321), HIKAL LTD (DMF 43901), HONOUR LAB LTD (DMF 40029) and HQ PHARMA (SHANGHAI) CO LTD (DMF 44102) and 8 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Cariprazine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Cariprazine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.